Conference Coverage at TheBodyPRO.com
- The Path to a Cure (January/February 2012)
The pathway to an HIV cure and other treatments in the pipeline.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Reaching Young Gay Men Through Grindr (January/February 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Germ Stories -- A Children's Book (January/February 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Risky Business and PrEP Interest in Chicago STI Clinic (January/February 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Switching From Atripla to Complera (January/February 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- HIV Prevention Begins With Knowing One's Own Risk, but Many Know Less Than They Think (October 17, 2011)
In The 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
ICAAC HIV Poster Roundup #2: Clinically Relevant Findings (September 20, 2011)
In The 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
Sangamo's SB-728 HIV Gene Therapy Approach Still Looks Sexy, but Leaves More Questions Than Answers (September 19, 2011)
In The 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
ICAAC HIV Poster Roundup #1: Clinically Relevant Findings (September 19, 2011)
In The 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
Ibalizumab Study Casts a Ray of Hope for HIV-Infected People With Extensive Drug Resistance (September 18, 2011)
In The 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
ICAAC 2011 Web Highlights
- Interferon May Reduce Liver Disease Progression in HIV/HCV Coinfected Relapsers (October 10, 2011)
From HIVandHepatitis.com
- Declining Prevalence of HIV Triple-Class and Protease Inhibitor Resistance (October 7, 2011)
From HIVandHepatitis.com
- New Integrase Inhibitor BI 224436 Active Against Raltegravir-Resistant HIV (October 7, 2011)
From HIVandHepatitis.com
- Monoclonal Antibody Ibalizumab May Hold Promise for Treatment-Experienced HIV Patients (October 4, 2011)
From HIVandHepatitis.com
- Intracellular Raltegravir Concentrations Better With Twice-Daily Than Once-Daily Dosing (September 30, 2011)
From National AIDS Treatment Advocacy Project
- Kidney Function Change With Cobicistat Calculated in HIV-Negative Volunteers (September 30, 2011)
From National AIDS Treatment Advocacy Project
- Omitting Inactive NRTIs From Salvage Regimen Can Maintain Viral Suppression (September 30, 2011)
From HIVandHepatitis.com
- Dolutegravir and Creatinine Clearance (September 26, 2011)
From National AIDS Treatment Advocacy Project
- An Open-Label, Placebo-Controlled Study to Evaluate the Effect of Dolutegravir (DTG, S/GSK1349572) on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects (September 26, 2011)
From National AIDS Treatment Advocacy Project
- Under 10% in Large Canadian Cohort Reach Normal CD4/CD8 Ratio (September 26, 2011)
From National AIDS Treatment Advocacy Project
VIEW ALL ARTICLES
Email
